309 related articles for article (PubMed ID: 28276323)
1. Preference for direct oral anticoagulants in patients treated with vitamin K antagonists for venous thromboembolism.
Brekelmans MP; Kappelhof M; Nieuwkerk PT; Nierman M; Buller HR; Coppens M
Neth J Med; 2017 Mar; 75(2):50-55. PubMed ID: 28276323
[TBL] [Abstract][Full Text] [Related]
2. When do patients prefer a direct oral anticoagulant over a vitamin K antagonist?
Boom MS; Berghuis EM; Nieuwkerk PT; Pinedo S; Büller HR
Neth J Med; 2015 Oct; 73(8):368-72. PubMed ID: 26478546
[TBL] [Abstract][Full Text] [Related]
3. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
[TBL] [Abstract][Full Text] [Related]
4. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
[TBL] [Abstract][Full Text] [Related]
5. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
Becattini C; Franco L; Beyer-Westendorf J; Masotti L; Nitti C; Vanni S; Manina G; Cattinelli S; Cappelli R; Sbrojavacca R; Pomero F; Marten S; Agnelli G
Int J Cardiol; 2017 Jan; 227():261-266. PubMed ID: 27843050
[TBL] [Abstract][Full Text] [Related]
6. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
[TBL] [Abstract][Full Text] [Related]
7. Direct oral anticoagulants are effective and safe for the treatment of venous thromboembolism associated with gynecological cancers.
Shimizu A; Sawada K; Shiomi M; Kawano M; Matsumoto Y; Takiuchi T; Kodama M; Kobayashi E; Hashimoto K; Mabuchi S; Ueda Y; Tomimatsu T; Kimura T
Int J Gynaecol Obstet; 2019 Nov; 147(2):252-257. PubMed ID: 31420876
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
Brekelmans MP; Bleker SM; Bauersachs R; Boda Z; Büller HR; Choi Y; Gallus A; Grosso MA; Middeldorp S; Oh D; Raskob G; Schwocho L; Cohen AT
Thromb Haemost; 2016 Jul; 116(1):155-61. PubMed ID: 27010092
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients.
Haas S; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Dalsgaard Nielsen J; Kayani G; Zaghdoun A; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK
J Thromb Haemost; 2019 Oct; 17(10):1694-1706. PubMed ID: 31220403
[TBL] [Abstract][Full Text] [Related]
10. Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register.
Palareti G; Antonucci E; Legnani C; Mastroiacovo D; Poli D; Prandoni P; Tosetto A; Pengo V; Testa S; Ageno W;
BMJ Open; 2020 Nov; 10(11):e040449. PubMed ID: 33247017
[TBL] [Abstract][Full Text] [Related]
11. Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran.
Leung TS; Law EH
Drug Des Devel Ther; 2015; 9():3557-69. PubMed ID: 26185422
[TBL] [Abstract][Full Text] [Related]
12. [Direct oral anticoagulants and drug-drug interactions].
Graf L; Korte W
Ther Umsch; 2015 Feb; 72(2):99-104. PubMed ID: 25630291
[TBL] [Abstract][Full Text] [Related]
13. Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients.
Kooistra HA; Veeger NJ; Khorsand N; Kluin-Nelemans HC; Meijer K; Piersma-Wichers M
Thromb Haemost; 2015 Apr; 113(4):881-90. PubMed ID: 25518854
[TBL] [Abstract][Full Text] [Related]
14. Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: a meta-analysis of randomized controlled trials.
Di Minno MN; Lupoli R; Di Minno A; Ambrosino P; Scalera A; Dentali F
Ann Med; 2015 Feb; 47(1):61-8. PubMed ID: 25665582
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
Bleker SM; Brekelmans MPA; Eerenberg ES; Cohen AT; Middeldorp S; Raskob G; Büller HR
Thromb Haemost; 2017 Oct; 117(10):1944-1951. PubMed ID: 28816341
[TBL] [Abstract][Full Text] [Related]
16. Persistence to direct oral anticoagulants for acute venous thromboembolism.
Dronkers CEA; Lijfering WM; Teichert M; van der Meer FJM; Klok FA; Cannegieter SC; Huisman MV
Thromb Res; 2018 Jul; 167():135-141. PubMed ID: 29843087
[TBL] [Abstract][Full Text] [Related]
17. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
18. Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials.
Wang W; Su Y; Wu C; Sun Y; Dai N; Chen W; Zhang J; Xu Y; Brindis RG; Xu D; Li J
BMC Cardiovasc Disord; 2020 Feb; 20(1):53. PubMed ID: 32013892
[TBL] [Abstract][Full Text] [Related]
19. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
Beyer-Westendorf J; Ageno W
Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
[TBL] [Abstract][Full Text] [Related]
20. Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: A systemic review and meta-analysis.
Yamashita Y; Morimoto T; Toyota T; Shiomi H; Makiyama T; Ono K; Kimura T
Thromb Res; 2018 Jun; 166():37-42. PubMed ID: 29655001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
